REVELATION BIOSCIENCES, INC. - 10-Q Filing

Revelation Biosciences, Inc. reports Q3 financial results featuring significant equity incentive activity and warrant classifications.

SEC EDGAR ·

Tickers: $REVB

Read the full article at SEC EDGAR

More Regulatory news